Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.39 |
| ▸ | IDE | P14735 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 7/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 6/20 | 0.39 |
| ▸ | RXRA | P19793 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | VHL | P40337 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.39 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.38 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6036002 | 0.90 | NR1H2 (0.45) | IDESMN1; SMN2NR1H3NR1H2RXRA | |
| SCHEMBL6035959 | 0.89 | PLA2G4B (0.42) | PLA2G4BIDESMN1; SMN2CYP4F2CYP4A11 | |
| SCHEMBL6036306 | 0.89 | NR1H3 (0.39) | PLA2G4BIDESMN1; SMN2CYP4F2CYP4A11 | |
| SCHEMBL6035583 | 0.89 | PLA2G4B (0.40) | PLA2G4BIDESMN1; SMN2CYP4F2CYP4A11 | |
| SCHEMBL6034711 | 0.88 | PPARA (0.43) | PLA2G4BIDESMN1; SMN2CYP4F2CYP4A11 | |
| SCHEMBL6036152 | 0.87 | PLA2G4B (0.43) | PLA2G4BIDESMN1; SMN2CYP4F2CYP4A11 | |
| SCHEMBL6035465 | 0.87 | PLA2G4B (0.39) | PLA2G4BIDESMN1; SMN2CYP4F2CYP4A11 | |
| SCHEMBL6035852 | 0.85 | PPARA (0.44) | IDESMN1; SMN2CYP4F2CYP4A11PPARG | |
| SCHEMBL6143205 | 0.85 | PPARA (0.44) | PLA2G4BNR1H3NR1H2RXRAALDH1A1 | |
| SCHEMBL6035924 | 0.85 | SMN1; SMN2 (0.39) | PLA2G4BIDESMN1; SMN2NR1H3NR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060148858-A1 | 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060148858-A1 | 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity | GPR119, SLC5A1, CYP4B1 | PLA2G4B 4180/4885IDE 488/4885SMN1; SMN2 4408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.